Item 1.01 Entry into Material Definitive Agreement.
On
The above summary of the Agreement does not purport to be complete and is qualified in its entirety to the full text of the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is qualified herein by this reference.
Item 3.02 Unregistered Sales of
The disclosures set forth above under Item 1.01 are incorporated herein by reference. The issuance by the Company of the shares of Common Stock in exchange for the surrender and cancellation of the Warrants is being made in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended.
Item 9.01 Financing Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 10.1* Warrant Exchange Agreement, datedJuly 31, 2020 , by and betweenRexahn Pharmaceuticals, Inc. andArmistice Capital Master Fund Ltd.
* Portions of this exhibit have been omitted in compliance with Item 601 of
Regulation S-K. 2
--------------------------------------------------------------------------------
© Edgar Online, source